A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology

Hepatocellular carcinoma (HCC) is a serious global health problem, and hepatitis B virus (HBV) infection remains the leading cause of HCC. It is standard care to administer antiviral treatment for HBV-related HCC patients with concurrent anti-cancer therapy. However, a drug with repressive effects o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Xiaofeng, Li, Jinchuan, Hao, Zheng, Ding, Rui, Qiao, Yanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420877/
https://www.ncbi.nlm.nih.gov/pubmed/36046748
http://dx.doi.org/10.3389/fcimb.2022.964469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420877/
https://www.ncbi.nlm.nih.gov/pubmed/36046748
http://dx.doi.org/10.3389/fcimb.2022.964469

Ejemplares similares